Form 8-K - Current report:
SEC Accession No. 0001104659-08-013522
Filing Date
2008-02-28
Accepted
2008-02-28 07:00:51
Documents
3
Period of Report
2008-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-6812_18k.htm 8-K 34422
2 EX-99.1 a08-6812_1ex99d1.htm EX-99.1 247978
3 GRAPHIC g68121mmi001.jpg GRAPHIC 3280
  Complete submission text file 0001104659-08-013522.txt   288604
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

EIN.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32966 | Film No.: 08648429
SIC: 2836 Biological Products, (No Diagnostic Substances)